LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 46c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q4 EPS of ($0.46).

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Costco (COST) Tops Q4 EPS by 20c
• Roblox (RBLX), Unity Software Inc. (U) Falls on Reports Meta to Let You Build Games with AI on Your Phone
• T-Mobile (TMUS) Raises Quarterly Dividend 14.7% to $1.17; 2.8% Yield